• LevelJump Healthcare (JUMP) has closed a non-brokered private placement for gross proceeds of $877,000.15
  • The company issued a total of 5,858,334 units priced at $0.15 per unit
  • Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology
  • Net proceeds will be used for acquisitions and for general working capital
  • Shares in Leveljump Healthcare Corp. (JUMP) opened trading at C$0.11

LevelJump Healthcare (JUMP) has closed its previously announced non-brokered private placement for gross proceeds of $877,000.15.

The company issued a total of 5,858,334 units priced at $0.15 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire one additional common share until January 31, 2024.

Net proceeds will be used for acquisitions and for general working capital.

All securities issued will be subject to a four-month holding period.

Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology. The company provides radiology solutions for hospitals, emergency rooms, and private clinics.

LevelJump Healthcare Corp. (JUMP) opened trading at C$0.11.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.